As of June 30, 2024, Biome Australia Ltd carries a market capitalization of 124.75M, placing it among publicly traded companies globally. Its enterprise value stands at 123.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 124.75M |
| Enterprise Value | 123.18M |
Biome Australia Ltd's next confirmed earnings release is scheduled for February 23, 2027.
| Earnings Date | 2/23/2027 |
As of June 30, 2024, Biome Australia Ltd has 215.09M shares outstanding.
| Shares Outstanding | 215.09M |
These figures are as of June 30, 2024. The price-to-sales ratio is 9.28, and the price-to-book ratio stands at 42.97.
| PS Ratio | 9.28 |
| PB Ratio | 42.97 |
| P/TBV Ratio | 42.97 |
These figures are as of June 30, 2024. The EV/Sales ratio of 9.47 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 123.18M versus a market cap of 124.75M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 9.47 |
As of June 30, 2024, Biome Australia Ltd maintains a current ratio of 1.50, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 44.65, indicating elevated leverage, while an interest coverage ratio of -11.31 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.50 |
| Quick Ratio | 1.12 |
| Debt / Equity | 44.65 |
| Debt / EBITDA | -0.77 |
| Interest Coverage | -11.31 |
Over the twelve months ended June 30, 2024, Biome Australia Ltd posted a negative return on equity (ROE) of -51.47, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -17.71, reflecting losses generated across the asset base. Inventory turnover of 1.29 indicates how many times Biome Australia Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -51.47 |
| Return on Assets (ROA) | -17.71 |
| Inventory Turnover | 1.29 |
As of the close on October 22, 2026, Biome Australia Ltd's stock has declined approximately 19.15% over the past 52 weeks. The 50-day moving average sits at 0.37, while the 200-day moving average is 0.34.
| 52-Week Price Change | -19.15% |
| 50-Day Moving Average | 0.37 |
| 200-Day Moving Average | 0.34 |
Over the twelve months ended June 30, 2024, Biome Australia Ltd generated 13.01M in revenue and converted that into -1.67M in net income, yielding earnings per share of -0.01. EBITDA reached -1.69M, while operating income came in at -1.93M.
| Revenue | 13.01M |
| Gross Profit | 7.91M |
| Operating Income | -1.93M |
| Pretax Income | -1.67M |
| Net Income | -1.67M |
| EBITDA | -1.69M |
| EBIT | -1.93M |
| Earnings Per Share (EPS) | -0.01 |
As of June 30, 2024, Biome Australia Ltd holds 2.87M in cash and equivalents against 1.30M in total debt, resulting in a net debt position of -1.85M. Total book value stands at 2.90M, with working capital of 2.56M providing operational flexibility.
| Cash & Cash Equivalents | 2.87M |
| Total Debt | 1.30M |
| Net Debt | -1.85M |
| Equity (Book Value) | 2.90M |
| Book Value Per Share | 0.01 |
| Working Capital | 2.56M |
These figures cover the twelve months ended June 30, 2024.
| Capital Expenditures | -21,607.00 |
Over the twelve months ended June 30, 2024, Biome Australia Ltd posted a gross margin of 60.81, reflecting its pricing power and cost economics. The operating margin of -14.87 and net profit margin of -12.84 provide insight into operational efficiency.
| Gross Margin | 60.81 |
| Operating Margin | -14.87 |
| Pretax Margin | -12.84 |
| Profit Margin | -12.84 |
| EBITDA Margin | -13.01 |
These figures cover the twelve months ended June 30, 2024. Total shareholder yield is negative at -0.64, meaning Biome Australia Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -0.64 |
As of June 30, 2024, Biome Australia Ltd has an Altman Z-Score of 11.84, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 11.84 |
Already premium?